Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major addictive substances studied, suggesting these drugs target a common biological pathway underlying addiction
Decrease glucagon secretion
Patients experiencing sudden vision changes should seek immediate medical attention and should not stop taking prescribed medication without consulting their healthcare provider, as other eye conditions such as glaucoma, diabetic retinopathy, or unrelated vascular disorders may also affect vision
Pancreatitis can be life-threatening if not treated promptly
Considering Brand-Name Tirzepatide: Mounjaro and Zepbound One notable set of tirzepatide alternatives we havent covered yet are the brand-name versions themselves: Mounjaro and Zepbound, both manufactured by Eli Lilly
Combining Ozempic and Mounjaro activates overlapping GLP-1 pathways simultaneously, causing severe nausea, vomiting, acute pancreatitis, and kidney injury in clinical experience